×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Glucose 6 Phosphate Dehydrogenase Deficiency Market

ID: MRFR/HC/35420-HCR
100 Pages
Rahul Gotadki
October 2025

Informe de investigación de mercado de Deficiencia de glucosa-6-fosfato deshidrogenasa por tipo de diagnóstico (ensayo enzimático, secuenciación de ADN, pruebas genéticas), por tipo de tratamiento (transfusión de sangre, suplementación con ácido fólico, terapia con hidroxiurea), por usuario final (hospitales, laboratorios de diagnóstico, instituciones de investigación), por modo de administración (oral, intravenoso, intramuscular) y por región (América del Norte, Europa, América del Sur, Asia) Pacífico, Medio Oriente y África) - Previsión ha... leer más

Compartir
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Glucose 6 Phosphate Dehydrogenase Deficiency Market Infographic
Purchase Options

Glucose 6 Phosphate Dehydrogenase Deficiency Market Resumen

Las empresas clave en el mercado Glucose 6 Phosphate Dehydrogenase Deficiency Market incluyen

Alcance del informe

Deja un comentario

FAQs

What is the current market valuation of the Glucose-6-Phosphate Dehydrogenase Deficiency Market?

As of 2024, the market valuation was 2.066 USD Billion.

What is the projected market size for the Glucose-6-Phosphate Dehydrogenase Deficiency Market by 2035?

The market is expected to reach a valuation of 3.715 USD Billion by 2035.

What is the expected CAGR for the Glucose-6-Phosphate Dehydrogenase Deficiency Market during the forecast period?

The market is projected to grow at a CAGR of 5.48% from 2025 to 2035.

Which companies are the key players in the Glucose-6-Phosphate Dehydrogenase Deficiency Market?

Key players include Pfizer Inc, Bristol-Myers Squibb Company, Bayer AG, Roche Holding AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Amgen Inc, and AbbVie Inc.

What are the main segments of the Glucose-6-Phosphate Dehydrogenase Deficiency Market?

The main segments include Diagnosis Type, Treatment Type, End User, and Mode of Delivery.

What was the market size for the Enzymatic Assay segment in 2024?

In 2024, the Enzymatic Assay segment was valued at 0.826 USD Billion.

How much is the Genetic Testing segment projected to be worth by 2035?

The Genetic Testing segment is expected to reach 1.118 USD Billion by 2035.

What is the projected market size for Blood Transfusion treatments by 2035?

Blood Transfusion treatments are anticipated to grow to 1.482 USD Billion by 2035.

Which end user segment is expected to have the highest valuation by 2035?

The Hospitals segment is projected to reach 1.5 USD Billion by 2035.

What is the expected growth for the Intravenous mode of delivery by 2035?

The Intravenous mode of delivery is likely to grow to 1.115 USD Billion by 2035.

Descargar muestra gratis

Complete el formulario a continuación para recibir una muestra gratuita de este informe

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions